DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR BOSULIF
» See Plans and Pricing
All Clinical Trials for Bosulif
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02228382 | Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors | Recruiting | Developmental Therapeutics Consortium | Phase 4 | 2014-11-01 | The purpose of this study is to fulfill the post-authorization commitment made by Pfizer to the European Medicines Agency in providing additional safety and efficacy data in approximately 150 Philadelphia Chromosome Positive Chronic Myeloid Leukemia patients with high unmet medical need, including 75 Chronic Phase, Accelerated Phase or Blast Phase patients in the fourth or later line treatment setting (i.e., after treatment with at least 3 other Tyrosine Kinase Inhibitors). |
| NCT02228382 | Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors | Recruiting | Pfizer | Phase 4 | 2014-11-01 | The purpose of this study is to fulfill the post-authorization commitment made by Pfizer to the European Medicines Agency in providing additional safety and efficacy data in approximately 150 Philadelphia Chromosome Positive Chronic Myeloid Leukemia patients with high unmet medical need, including 75 Chronic Phase, Accelerated Phase or Blast Phase patients in the fourth or later line treatment setting (i.e., after treatment with at least 3 other Tyrosine Kinase Inhibitors). |
| NCT02501330 | Safety And Efficacy Of Bosutinib | Active, not recruiting | Pfizer | N/A | 2015-07-01 | The objective of this surveillance is to collect information about 1. adverse drug reaction not expected from the LPD (unknown adverse drug reaction) 2. the incidence of adverse drug reactions in this surveillance 3. factors considered to affect the safety and/or efficacy of this drug. |
| NCT02546375 | A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands | Active, not recruiting | pH Associates | N/A | 2015-07-01 | The purpose of this study is to describe the efficacy and safety of bosutinib in patients with chronic myeloid leukaemia used in a real world setting |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Bosulif
Clinical Trial Locations for Bosulif
Trials by Country
Clinical Trial Progress for Bosulif
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Bosulif
Sponsor Name
